(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of hypersensitivity is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that a xience alpine stent was implanted on (b)(6) 2019.On (b)(6) 2019, the patient presented with upper extremity swelling, tingling and the inability to raise their arms above their head, thought to be a possible allergic reaction.The statin was changed, and steroids given.A blood panel came back normal with normal ejection fraction.The patient continues to have symptoms and may be tested for an allergic reaction to the stent at a future date.No additional information was provided.
|